Elucidating an uncommon disease: inflammatory breast cancer. [electronic resource]
Producer: 20111108Description: 1358-60 p. digitalISSN:- 1460-2105
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Cadherins -- metabolism
- Carboplatin -- administration & dosage
- Carcinoma, Ductal, Breast -- diagnosis
- Chemotherapy, Adjuvant
- Clinical Trials as Topic
- Diagnosis, Differential
- Docetaxel
- Drug Resistance, Neoplasm
- Female
- Humans
- Inflammatory Breast Neoplasms -- diagnosis
- Lapatinib
- Mastitis -- diagnosis
- Molecular Targeted Therapy -- methods
- Neoadjuvant Therapy -- methods
- Neoplasm Staging
- Neoplastic Cells, Circulating -- pathology
- Quinazolines -- administration & dosage
- Receptor, ErbB-2 -- metabolism
- Remission Induction
- Taxoids -- administration & dosage
- Transforming Growth Factor beta -- metabolism
- Trastuzumab
- Treatment Outcome
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.